Found 352 oncology trials
A listing of oncology medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Please refer to Protocol Section 3. (OBJECTIVES AND ENDPOINTS). Please refer to Protocol Section 3. (OBJECTIVES AND ENDPOINTS). Please refer to Protocol Section 3. (OBJECTIVES AND ENDPOINTS).
The research study is for Glioblastoma (GBM) patients beginning Optune, a therapy that uses - tumor treating fields (TTFields). As a part of this study participants will either receive Optune with standard treatment array mapping from MR imaging or an alternative treatment array mapping based on advanced MR imaging also …
The purpose of this research study is to help identify the difference between cancerous and non-cancerous salivary gland tumors for improving treatment strategies and also aid in the prediction of disease progression. It is important to determine whether the salivary gland tumor is cancerous prior to operation because this information …
The purpose of the study is to assess whether an investigational drug, called XmAb20717, has any effects on certain types of cancers and if it is safe and well tolerated.
This is a study to evaluate the efficacy and safety of Belzutifan monotherapy in participants with advanced pheochromocytoma/paraganglioma (PPGL) or pancreatic neuroendocrine tumor (pNET). The primary objective of the study is to evaluate the objective response rate (ORR) of belzutifan per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST …
This is a first-in-human Phase 1a/1b multicenter, open-label study designed to evaluate the safety and anti-cancer activity of NX-5948 in patients with advanced B-cell malignancies. We would like to rely on WCG IRB as the IRB of record for this study.
This EAP is designed to confirm the safety, tolerability, and performance of PET/CT imaging with 89Zr-DFO-girentuximab to non-invasively detect ccRCC in patients with imaging evidence of renal mass(es) at conventional imaging. This protocol is to explore the feasibility of further development of [18F]FTT as a PARP-1 imaging agent. We will …
The purpose of this study is to test a new scanner device that combines two types of imaging called Breast Positron Emission Tomography (BPET) and Digital Breast Tomosynthesis (DPT) for imaging of a radioactive imaging drug called 18F-Fluoroestradiol (FES), as a diagnostic device for imaging estrogen receptor (ER) positive breast …
This study will evaluate the long-term (up to 15 years) safety and efficacy of CRISPR CAR cellular therapy for hematological and solid malignancies. We would like to rely on WCG as the local IRB of record for this study.
